abstract |
CYCLOEXAN-1,4-DIAMINES REPLACED BY PIPERIDINYL. The present invention relates to piperidine-substituted cyclohexane-1,4-diamine compounds according to Formula (1) and pharmaceutically acceptable forms thereof as β2-Î ± 1Î ± -β-1d-adrenoreceptor modulators. for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said novel compounds, novel processes for preparing these novel compounds and novel uses as a medicament as well as methods of treatment. |